Investigational Staphylococcus aureus Vaccine Begins Trial

Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this digitally colorized, scanning electron microscopic (SEM) image, depicts a clump of yellow-colored, spheroid shaped, Staphylococcus aureus bacteria that were enmeshed in a blue-colored, filamentous extracellular matrix, which normally binds cells together within the body’s various tissue types. Image credit: National Institute of Allergy […]
Measles Outbreak in Texas Expands to 58 Cases, Hospitalizations Increase

Measles rash Image credits: Unsplash The Texas Department of State Health Services (DSHS) has an updated report of the ongoing measles outbreak in the South Plains region of Texas. As of February 18, 2025, 58 cases have been identified, with symptoms starting within the past three weeks. 13 patients have been hospitalized, and four of […]
Designing antivirals for shape-shifting viruses

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic — constantly evolving and changing shape, which can make designing antiviral treatments a challenge. But new research utilizes an innovative computational modeling approach to […]
FDA Sets PDUFA Date for Lenacapavir For HIV Prevention

This morning, Gilead announced the FDA has accepted its new drug application (NDA) submissions for lenacapavir for the prevention of HIV as PrEP.1 The FDA will review the applications under priority review and has assigned a PDUFA target action date of June 19, 2025. If lenacapavir does get approved, it will be the first and […]
Community Engagement and Data Practices

Observational studies have long played a pivotal role in clinical research and public health responses during epidemics. These studies provide vital data that inform early decisions, particularly in the early stages of an outbreak when time is of the essence. Tthey offer immense value, they also come with challenges, especially regarding data accuracy, relevance, and […]
Advances in Treatment and Prevention of HIV
Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition and provides the tools that might lead to an end of the HIV pandemic. Despite these advances, in the United States there were approximately 30 000 new infections in 2022, less than 70% of people living with HIV were virologically suppressed, […]
IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults
This Special Communication from the International Antiviral Society–USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention. Source link
Changes to CDC’s Website Threaten Patients, Public Health
This Medical News article discusses the impact of President Donald Trump’s executive orders on the information available on CDC.gov, an important resource for clinicians, researchers, and the public. Source link